The classical vs nonclassical NSAIDs
Comprehensive Therapy · 2006
DOI: 10.1007/bf02698073 ↗At a glance
Übersichtsarbeit in Comprehensive Therapy, 2006. Written by Wasim Haque and 3 co-authors. Institution: Thrombo Therapeutics Inc., 103 Advanced Technology Center, Edmonton, Alberta, CA, USA. ckubnic@lumc.edu. 32 references.
Abstract (original language)
The advent of cyclooxygenase-2 inhibitors has been both a blessing and a curse for pain management. An in-depth understanding of the biological molecules in the arachidonic acid metabolism may alleviate pain without risk.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Thrombo Therapeutics Inc., 103 Advanced Technology Center, Edmonton, Alberta, CA, USA. ckubnic@lumc.edu
Cite
APA
Haque, W., Fareed, J., Wehrmacher, W. H., & Messmore, H. L. (2006). The classical vs nonclassical NSAIDs. Comprehensive Therapy. https://doi.org/10.1007/bf02698073
Vancouver
Haque W, Fareed J, Wehrmacher WH, Messmore HL. The classical vs nonclassical NSAIDs. Comprehensive Therapy. 2006. doi:10.1007/bf02698073
BibTeX
@article{Haque2006,
author = {Haque, Wasim and Fareed, Jawed and Wehrmacher, William H and Messmore, Harry L},
title = {The classical vs nonclassical NSAIDs},
journal = {Comprehensive Therapy},
year = {2006},
doi = {10.1007/bf02698073}
}
EUVIMED